Trelstar LA Related Clinical Trials
Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg [Recruiting]
Study to Assess the Non-Inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT) [Recruiting]
Efficacy, Safety, and PK of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty [Recruiting]
HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer. [Recruiting]
Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer [Recruiting]
Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty [Recruiting]
Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer [Recruiting]
A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients. [Not yet recruiting]
Triptorelin for Ovary Protection in Childhood Onset Lupus [Recruiting]
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus [Recruiting]
Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer [Recruiting]
Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin [Completed]
Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer [Recruiting]
Study to Evaluate a Subcutaneous Four Months Sustained-Release Formulation of Triptorelin in Patients With Prostate Cancer [Terminated]
Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study [Recruiting]
Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer [Completed]
Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery [Completed]
Endometrial Receptivity After GnRH Agonist Triggering [Recruiting]
Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02 [Recruiting]
Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer [Recruiting]
Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer [Recruiting]
A 4 Year Combination Therapy of Growth Hormone (GH) and Gonadotropin-Releasing Hormone (GnRH) Agonist in Children With a Short Predicted Height [Recruiting]
Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG-2402 [Recruiting]
Tamoxifen Citrate Alone or Ovarian Function Suppression and Tamoxifen Citrate or Exemestane in Treating Premenopausal Women Who Have Undergone Surgery for Breast Cancer [Recruiting]
GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles [Completed]
Luteal-Phase GnRH Agonist Administration in Frozen-Thawed IVF Embryo Transfer Cycles [Not yet recruiting]
Hormone Therapy in Treating Patients With Advanced Prostate Cancer [Active, not recruiting]
Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome? [Not yet recruiting]
Maintenance Therapy of Levonorgestrel-releasing Intrauterine System (LNG-IUS) to Prevent the Recurrence of Symptomatic Endometriosis After Conservative Surgery [Recruiting]
Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Women With Hormone Receptor-Positive Breast Cancer That Can be Removed by Surgery [Recruiting]
Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days [Recruiting]
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer [Recruiting]
Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration [Recruiting]
The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis [Recruiting]
Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression [Not yet recruiting]
GP Extended Action Triptorelin [Recruiting]
Investigation of Early Hormonotherapy Efficacy of Prostate Cancer [Recruiting]
Suppression of Ovarian Function and Either Tamoxifen or Exemestane With or Without Chemotherapy in Treating Premenopausal Women With Resected Breast Cancer [Completed]
Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children [Recruiting]
Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders [Completed]
Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients [Recruiting]
Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation [Recruiting]
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy [Recruiting]
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse [Recruiting]
Decapeptyl SR With Livial Add Back Therapy in the Management of Chronic Cyclical Pelvic Pain in Pre Menopausal Women [Recruiting]
Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients [Not yet recruiting]
Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation [Recruiting]
Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients [Recruiting]
Antagonist/Letrozole in Poor Responders [Recruiting]
Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatment [Recruiting]
|
